Literature DB >> 11254912

Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta.

R Tamura1, J Miyagawa, M Nishida, S Kihara, R Sasada, K Igarashi, A Nakata, K Yamamori, K Kameda-Takemura, S Yamashita, Y Matsuzawa.   

Abstract

Betacellulin (BTC), a new member of the EGF family, has been reported to be a potent mitogen for rat vascular smooth muscle cells (SMCs). BTC mRNA is known to be expressed in several human organs. However, the localization of BTC in human vascular tissues has not yet been clarified. We investigated whether or not BTC protein is involved in the pathogenesis of human atherosclerosis. Recombinant human BTC showed a mitogenic activity on cultured human aortic SMCs by measuring [3H]thymidine incorporation. The immunohistochemical localization of BTC, SMCs, macrophages, EGF receptors and ErbB4 was examined in autopsied human aortas. BTC was detected in both intimal and medial SMCs of the aortic wall. The percentage of BTC-positive medial SMCs in early types of atherosclerotic lesions decreased with age, but in adult, it was significantly higher in advanced types than in early types of atherosclerotic lesions. BTC-positive SMCs were predominantly localized in the medial side of the intima. Furthermore, numerous BTC-positive SMCs and macrophages were observed around the core lesion of atherosclerotic plaques. Receptors for BTC, EGF receptor and ErbB4, were expressed on SMCs, suggesting that BTC is associated with EGF receptor family-mediated signaling. BTC is produced in human aortic tissue and might play important roles in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254912     DOI: 10.1016/s0021-9150(00)00576-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

2.  Periadventitial delivery of anti-EGF receptor antibody inhibits neointimal macrophage accumulation after angioplasty in a hypercholesterolaemic rabbit.

Authors:  Shahida Shafi; David Lamb; Helmout Modjtahedi; Gordon Ferns
Journal:  Int J Exp Pathol       Date:  2009-12-11       Impact factor: 1.925

3.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

4.  Mig-6 gene knockout induces neointimal hyperplasia in the vascular smooth muscle cell.

Authors:  Ju Hee Lee; Sorim Choung; Ji Min Kim; Jung Uee Lee; Koon Soon Kim; Hyun Jin Kim; Jae-Wook Jeong; Bon Jeong Ku
Journal:  Dis Markers       Date:  2014-12-10       Impact factor: 3.434

5.  Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress.

Authors:  Lintao Wang; Zhouqing Huang; Weijian Huang; Xuemei Chen; Peiren Shan; Peng Zhong; Zia Khan; Jingying Wang; Qilu Fang; Guang Liang; Yi Wang
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

6.  The mineralocorticoid receptor leads to increased expression of EGFR and T-type calcium channels that support HL-1 cell hypertrophy.

Authors:  Katharina Stroedecke; Sandra Meinel; Fritz Markwardt; Udo Kloeckner; Nicole Straetz; Katja Quarch; Barbara Schreier; Michael Kopf; Michael Gekle; Claudia Grossmann
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

7.  R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome.

Authors:  Lin-Bo Gao; Bin Zhou; Lin Zhang; Ye-Sheng Wei; Yan-Yun Wang; Wei-Bo Liang; Mei-Li Lv; Xin-Min Pan; Yu-Cheng Chen; Li Rao
Journal:  BMC Med Genet       Date:  2008-07-30       Impact factor: 2.103

8.  Growth factors serum levels in coronary artery disease patients scheduled for bypass surgery: perioperative dynamics and comparisons with healthy volunteers.

Authors:  Inga Karu; Joel Starkopf; Kersti Zilmer; Mihkel Zilmer
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.